File #2367: "2018_Book_TowardsMoreEffectiveGlobalDrug.pdf"
Testo
1|Contents|5
1|1 Introduction|7
2|A Crossroads for Global Drug Policy?|7
2|A Public Criminology Approach|14
2|Structure of the Book|18
2|References|23
1|2 Step One: Acknowledge the Failure of a War on Drugs Strategy and the Harm it has Caused|26
2|The Rise of Prohibition Based Drug Policy|26
2|The Emergence of a War on Drugs|29
2|Failure of War on Drugs|32
2|Unintended and Harmful Consequences: Consumer Countries|34
2|Unintended and Harmful Consequences: Producer Countries|36
2|The Endurance of a War on Drugs Approach|39
3|Policy Developments Arising from the Proliferation of New Psychoactive Substances (NPS)|40
3|International Drug Conventions and Official Drug Policy Discourse|44
2|Conclusion|49
2|References|50
1|3 Step Two: Recognise the Primary Importance of Addressing the Harm That Stems From and is Associated With Drug Use and Drug Control Policies|57
2|A Harm Reduction Approach to Drug Policy|59
2|The Evolution and Limitations of Harm Reduction as an Alternative Strategy of Drug Control|64
2|Addressing the Harm That Arises from Social and Material Inequality|70
2|Addressing the Harm That Is Experienced by Drug Producing Countries and That Arises as a Result of Human Rights Abuses|73
2|How Prevalent Is the Concept of Harm Reduction in Existing Systems of Drug Control?|76
3|Harm Reduction’s Narrow Global Reach|77
3|Portugal as an Isolated Example of National Drug Policy Grounded in Harm Reduction|79
3|Reference to Harm Reduction in Official International Drug Policy Documentation|84
2|Conclusion|87
2|References|89
1|4 Step Three: Encourage the Development of Innovative Strategies of Drug Control|94
2|Room for Manoeuvre: Flexibility Within the International Drug Conventions|96
2|Variety and Innovation in Cannabis Control Around the Globe|98
3|The Not-for-Profit Collective Cultivation Model: Cannabis Clubs in Spain|100
3|Cannabis Use for Medical and Religious Purposes: The Jamaican Drug Law Amendment|103
3|A Partially Regulated Market: Coffeeshop Policy in the Netherlands|106
3|Fully Regulated Markets: US States and Uruguay|108
2|The Benefits of Diversity and Innovation in Drug Policy|113
2|Limitations to Drug Policy Innovation|116
2|Reform of the International Drug Policy Conventions|118
2|Conclusion|122
2|References|123
1|5 Step Four: Ensure That Drug Policy Innovations are Evaluated, and Evidence on Their Effectiveness is Shared Widely|128
2|Evidence Based Policy|129
2|Evidence-Based Drug Policy|133
2|Cross-National Comparative Research and the Development of Metrics of Drug Policy Effectiveness|137
2|Policy Transfer and Lesson Drawing: Another Kind of Evidence|146
2|Conclusion|153
2|References|154
1|6 Step Five: Broaden the Horizons of the Drug Policy Debate|159
2|Including the Global South|160
2|Including the Local Level|167
2|Including a Greater Variety of Potentially Harmful Substances|171
2|Including the Full Range of Drug Scene Developments|178
2|Conclusion|186
2|References|186
1|7 Conclusion|194
2|Obstacles to Implementing More Effective Global Drug Policies|200
2|Nature of Global Drug Policy Change|204
2|References|209
1|References|213
1|Index|242
1|1 Introduction|7
2|A Crossroads for Global Drug Policy?|7
2|A Public Criminology Approach|14
2|Structure of the Book|18
2|References|23
1|2 Step One: Acknowledge the Failure of a War on Drugs Strategy and the Harm it has Caused|26
2|The Rise of Prohibition Based Drug Policy|26
2|The Emergence of a War on Drugs|29
2|Failure of War on Drugs|32
2|Unintended and Harmful Consequences: Consumer Countries|34
2|Unintended and Harmful Consequences: Producer Countries|36
2|The Endurance of a War on Drugs Approach|39
3|Policy Developments Arising from the Proliferation of New Psychoactive Substances (NPS)|40
3|International Drug Conventions and Official Drug Policy Discourse|44
2|Conclusion|49
2|References|50
1|3 Step Two: Recognise the Primary Importance of Addressing the Harm That Stems From and is Associated With Drug Use and Drug Control Policies|57
2|A Harm Reduction Approach to Drug Policy|59
2|The Evolution and Limitations of Harm Reduction as an Alternative Strategy of Drug Control|64
2|Addressing the Harm That Arises from Social and Material Inequality|70
2|Addressing the Harm That Is Experienced by Drug Producing Countries and That Arises as a Result of Human Rights Abuses|73
2|How Prevalent Is the Concept of Harm Reduction in Existing Systems of Drug Control?|76
3|Harm Reduction’s Narrow Global Reach|77
3|Portugal as an Isolated Example of National Drug Policy Grounded in Harm Reduction|79
3|Reference to Harm Reduction in Official International Drug Policy Documentation|84
2|Conclusion|87
2|References|89
1|4 Step Three: Encourage the Development of Innovative Strategies of Drug Control|94
2|Room for Manoeuvre: Flexibility Within the International Drug Conventions|96
2|Variety and Innovation in Cannabis Control Around the Globe|98
3|The Not-for-Profit Collective Cultivation Model: Cannabis Clubs in Spain|100
3|Cannabis Use for Medical and Religious Purposes: The Jamaican Drug Law Amendment|103
3|A Partially Regulated Market: Coffeeshop Policy in the Netherlands|106
3|Fully Regulated Markets: US States and Uruguay|108
2|The Benefits of Diversity and Innovation in Drug Policy|113
2|Limitations to Drug Policy Innovation|116
2|Reform of the International Drug Policy Conventions|118
2|Conclusion|122
2|References|123
1|5 Step Four: Ensure That Drug Policy Innovations are Evaluated, and Evidence on Their Effectiveness is Shared Widely|128
2|Evidence Based Policy|129
2|Evidence-Based Drug Policy|133
2|Cross-National Comparative Research and the Development of Metrics of Drug Policy Effectiveness|137
2|Policy Transfer and Lesson Drawing: Another Kind of Evidence|146
2|Conclusion|153
2|References|154
1|6 Step Five: Broaden the Horizons of the Drug Policy Debate|159
2|Including the Global South|160
2|Including the Local Level|167
2|Including a Greater Variety of Potentially Harmful Substances|171
2|Including the Full Range of Drug Scene Developments|178
2|Conclusion|186
2|References|186
1|7 Conclusion|194
2|Obstacles to Implementing More Effective Global Drug Policies|200
2|Nature of Global Drug Policy Change|204
2|References|209
1|References|213
1|Index|242